An entirely new category of medicine is emerging, and a new wave of digital therapeutics start-ups is joining the effort to bring meaning and definition to this new industry.
What started out six years ago as a local ‘passion project’ for Bayer to collaborate with Berlin’s digital health scene has grown into a truly global programme.
AstraZeneca’s new R&D headquarters in Cambridge may be having teething problems – but ironically the site at Alderley Park, Cheshire that it abandoned nearly five years ago is going fro
A service that helps patients capture and share their experience and outcomes of care, in settings from trials to the clinic, is one of three 2018 Pfizer Healthcare Hub Challenge winners.
Pharma giant Pfizer is injecting $600 million into its venture investment arm in a bid to ramp up its involvement in biotechnology and other emerging growth companies.